21 February 2018
News and Views
Links and Services
A study in January's Alimentary Pharmacology & Therapeutics evaluates idiopathic inflammatory demyelinating disease of the central nervous system in patients with inflammatory bowel disease.
Anti-TNFα biologics induce and maintain remission in inflammatory bowel disease (IBD).
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors